Literature DB >> 25120762

Identification of collaboration patterns of dysfunctional pathways in breast cancer.

Xinyong Zhu1, Lianyuan Tao2, Jing Yao1, Pengjun Sun1, Lijuan Pei1, Jiye Li1, Zhihua Long2, Ye Wang2, Fengliang Zhang2.   

Abstract

Breast cancer (BC) is the most common malignancy among women. We aimed to illuminate the molecular dysfunctional mechanisms of BC progression. The mRNA expression profile of BC GSE15852 was downloaded from Gene Expression Omnibus database, including 43 normal samples and 43 cancer samples. Differentially expressed genes (DEGs) in BC were screened using the t-test by Benjamin and Hochberg method. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of the selected DEGs were enriched using Hypergeomeric distribution model. In addition, functional similarity network among the enriched pathways was constructed to further analyze the collaboration of these pathways. We found 848 down-regulated DEGs were associated with 16 significant dysfunctional pathways, including PPAR signaling fatty acid metabolism, and 1584 up-regulated DEGs were related to 6 significant dysfunctional pathways, like cell cycle, protein export, and antigen processing and presentation in BC samples. Crosstalk network analysis of pathways indicated that pyruvate metabolism, propanoate metabolism, and glycolysis gluconeogenesis were the pathways with closest connections with other pathways in BC. In addition, other antigen processing and presentation, including 19 DEGs; PPAR signaling pathway, including 18 DEGs; and pyruvate metabolism pathway, including 13 DEGs were further analyzed. Our results suggested that dysfunctional of significant pathways can greatly affect the progression of BC. Several significant disorder pathways were enriched in our comprehensive study. They may provide guidelines to explore the dysfunctional mechanism of BC progression.

Entities:  

Keywords:  Breast cancer; differentially expressed genes; dysfunctional; pathway crosstalk

Mesh:

Substances:

Year:  2014        PMID: 25120762      PMCID: PMC4128997     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  54 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Role of the heat shock response and molecular chaperones in oncogenesis and cell death.

Authors:  C Jolly; R I Morimoto
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

Review 3.  Peroxisome-proliferator-activated receptors and cancers: complex stories.

Authors:  Liliane Michalik; Béatrice Desvergne; Walter Wahli
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

4.  An evaluation of the quality of life among long-term survivors of breast cancer.

Authors:  K H Dow; B R Ferrell; S Leigh; J Ly; P Gulasekaram
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.

Authors:  G Chinetti; S Lestavel; V Bocher; A T Remaley; B Neve; I P Torra; E Teissier; A Minnich; M Jaye; N Duverger; H B Brewer; J C Fruchart; V Clavey; B Staels
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

6.  Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts.

Authors:  E S Pizer; J Thupari; W F Han; M L Pinn; F J Chrest; G L Frehywot; C A Townsend; F P Kuhajda
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

Review 7.  Acyl-coenzyme A:cholesterol acyltransferase.

Authors:  T Y Chang; C C Chang; D Cheng
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

8.  A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

Authors:  Beat Thürlimann; Aparna Keshaviah; Alan S Coates; Henning Mouridsen; Louis Mauriac; John F Forbes; Robert Paridaens; Monica Castiglione-Gertsch; Richard D Gelber; Manuela Rabaglio; Ian Smith; Andrew Wardley; Andrew Wardly; Karen N Price; Aron Goldhirsch
Journal:  N Engl J Med       Date:  2005-12-29       Impact factor: 91.245

9.  Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.

Authors:  E S Pizer; C Jackisch; F D Wood; G R Pasternack; N E Davidson; F P Kuhajda
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

10.  ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization.

Authors:  S Cases; S Novak; Y W Zheng; H M Myers; S R Lear; E Sande; C B Welch; A J Lusis; T A Spencer; B R Krause; S K Erickson; R V Farese
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

View more
  3 in total

1.  Gene prioritization, communality analysis, networking and metabolic integrated pathway to better understand breast cancer pathogenesis.

Authors:  Andrés López-Cortés; César Paz-Y-Miño; Alejandro Cabrera-Andrade; Stephen J Barigye; Cristian R Munteanu; Humberto González-Díaz; Alejandro Pazos; Yunierkis Pérez-Castillo; Eduardo Tejera
Journal:  Sci Rep       Date:  2018-11-12       Impact factor: 4.379

2.  Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density.

Authors:  Benedetta Bendinelli; Alessia Vignoli; Domenico Palli; Melania Assedi; Daniela Ambrogetti; Claudio Luchinat; Saverio Caini; Calogero Saieva; Paola Turano; Giovanna Masala
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

3.  Integrative genomic analysis of N6-methyladenosine-single nucleotide polymorphisms (m6A-SNPs) associated with breast cancer.

Authors:  Zixue Xuan; Yiwen Zhang; Jinying Jiang; Xiaowei Zheng; Xiaoping Hu; Xiuli Yang; Yanfei Shao; Guobing Zhang; Ping Huang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.